May 14, 2026 04:40PM
Feb 18, 2026 05:00PM
Feb 18, 2026 05:00PM
Nov 19, 2025 09:14AM
Nov 19, 2025 09:13AM
Nov 10, 2025 04:05PM
Oct 27, 2025 06:33AM Novartis CEO defends $12 billion deal for Avidity as 'appropriate risk to take'
Oct 13, 2025 09:01AM
Oct 13, 2025 09:00AM
Oct 6, 2025 09:00AM
Sep 11, 2025 08:18AM
Sep 10, 2025 10:06AM
Sep 10, 2025 07:00AM
Sep 10, 2025 07:00AM Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44
Aug 30, 2025 04:00PM
Aug 7, 2025 04:05PM
Jul 28, 2025 09:00AM
Jul 28, 2025 09:00AM
Jul 23, 2025 09:00AM
Jul 23, 2025 09:00AM
Jul 10, 2025 06:23AM Goldman Sachs Resumes Avidity Biosciences (RNA) at Buy
Jun 11, 2025 09:00AM
Jun 10, 2025 06:40AM
Jun 9, 2025 12:51PM
Jun 9, 2025 07:01AM
Jun 9, 2025 07:01AM
Jun 9, 2025 07:00AM
May 13, 2025 06:59AM Avidity Biosciences (RNA) PT Lowered to $68 at H.C. Wainwright
May 8, 2025 04:05PM
Apr 8, 2025 09:02AM
Apr 8, 2025 09:00AM
Mar 31, 2025 09:00AM
Mar 18, 2025 06:41AM
Mar 17, 2025 07:08AM
Mar 17, 2025 07:00AM Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duc
Mar 11, 2025 04:12PM
Mar 7, 2025 07:08AM
Feb 27, 2025 04:05PM
Jan 8, 2025 09:00AM
Jan 6, 2025 02:00PM
Dec 22, 2024 04:00AM
Nov 12, 2024 07:00AM Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations
Nov 7, 2024 04:05PM
Oct 30, 2024 08:01AM
Oct 30, 2024 08:00AM
Oct 21, 2024 08:27AM
Oct 4, 2024 07:26AM
Oct 3, 2024 09:54AM
Oct 3, 2024 07:00AM Avidity Biosciences Inc. (RNA) Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran
Oct 3, 2024 07:00AM

322,996 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All